HANSOH PHARMA_Providing professional financial news and data related to HANSOH PHARMA, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Hansoh Pharmaceutical (03692.HK): HS-20093 Meets Primary Endpoint in Phase III Osteosarcoma Trial, to Advance NDA Filing

Tags：

HANSOH PHARMA 03692.HK

2026-07-28

HANSOH PHARMA(03692.HK): NDA for HS-10568 Injection Accepted by NMPA for Secondary Hyperparathyroidism in Dialysis Patients

Tags：

HANSOH PHARMA 03692.HK New Drug Application

2026-06-10

Finance
Mediwelcome Healthcare (02159.HK): Expected to Swing to Profit in Interim Period, Net Profit of No Less Than RMB 17 Million
Finance
Nanhua Futures Co., Ltd. (02691.HK): Overseas Subsidiary Granted Non-Trading Membership of London Stock Exchange
Finance
Youran Dairy (09858.HK): Expected to Swing to Profit in Interim Period, Profit Attributable to Owners Ranging from RMB 739 Million to RMB 903 Million
Finance
WK Group (02535.HK): Profit Warning, Expected Interim Loss of Not Less Than HK$10 Million
Research
Autonomous Driving Concept Stocks Watch | RoboSense (02498.HK) Trades Volatilely Lower in Afternoon Session; Institution Reports L2 Standard Equipment Penetration at 34.7% for Passenger Vehicles Jan-Apr 2026
Finance
UNISOUND AI TECHNOLOGY (09678.HK): Full Upgrade of U2-ASR and U2-TTS Voice Large Models
Finance
Hengrui Pharmaceuticals (01276.HK): SHR-4375 Injection Granted FDA Orphan Drug Designation
Finance
Kaisa Health Group(00876.HK): Hydromorphone Hydrochloride Injection of Qinghai Pharmaceutical Obtains Drug Registration Certificate
Finance
Mega Genomics Limited(06667.HK): Change of Company Secretary, Authorised Representative and Process Agent
Finance
Hengrui Pharmaceuticals (01276.HK): HRS-1780 Tablets Obtains Clinical Trial Approval Notice

Scan QR Code

Download App